TY - JOUR
T1 - Synthesis of 4-aminoantipyrine Schiff bases and their antimicrobial activities
AU - Oladeji, Olatunde S.
AU - Ikhile, Monisola I.
AU - Fotsing, Carine M.D.
AU - Mamo, Messai
AU - Ndungu, Patrick G.
AU - Ndinteh, Derek T.
N1 - Publisher Copyright:
© Journal of Chinese Pharmaceutical Sciences, School of Pharmaceutical Sciences, Peking University.
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Various compounds of 4-aminoantipyrine Schiff bases (M 1 -M 12 ) were synthesized via a condensation reaction of 4-aminoantipyrine with different benzaldehydes through a conventional method of refluxing the mixture for 3-4 h. The synthesizedSchiff bases were characterized by using elemental analyses, FT-IR, UV-Vis, Mass, 1H and 13C NMR spectroscopy. The antimicrobial activity of the synthesized Schiff bases was investigated against 12 bacterial strains(Mycobacterium smegmatis, Bacillus cereus, Bacillus subtilis, Enterococcus faecalis, Staphylococcus epidermidis, Klebsiella pneumonia, Escherichia coli, Enterobacter cloacae,Klebsiella oxytoca, Proteus vulgaris, Enterobacter aerogenes, and Pseudomonas aeruginosa), and antifungal activities were tested against seven fungal strains (Aspergillus flavus, Aspergillus carbonarious, Aspergillus parasiticus, Aspergillus fumigatus,Aspergillus niger, Fusarium verticillioides and Fusarium proliferatum). The antimicrobial activities of the synthesized compounds were compared with standard streptomycin and nalidixicacid. The results obtained from antibacterial assay indicated that M 1 -M 12 inhibited potential growth of Proteus vulgaris with minimum inhibitory concentrations (MICs) ranging from 15.6-250 μg/mL compared with the standard nalidixic acid with an MIC of 500 μg/mL. Moreover, we could conclude that most of the tested compounds experienced mild to low activities at 15.6 μg/mL. Their activities could be attributed to their low concentrations.The antifungal analysis showed that the tested fungi were not sensitive to the prepared Schiff bases at the prepared concentration of 500 μg/mL. Therefore, we recommended further analysis on both cytotoxicity and minimum bactericidal concentration (MBC) to ascertain their potential effects against human cells.
AB - Various compounds of 4-aminoantipyrine Schiff bases (M 1 -M 12 ) were synthesized via a condensation reaction of 4-aminoantipyrine with different benzaldehydes through a conventional method of refluxing the mixture for 3-4 h. The synthesizedSchiff bases were characterized by using elemental analyses, FT-IR, UV-Vis, Mass, 1H and 13C NMR spectroscopy. The antimicrobial activity of the synthesized Schiff bases was investigated against 12 bacterial strains(Mycobacterium smegmatis, Bacillus cereus, Bacillus subtilis, Enterococcus faecalis, Staphylococcus epidermidis, Klebsiella pneumonia, Escherichia coli, Enterobacter cloacae,Klebsiella oxytoca, Proteus vulgaris, Enterobacter aerogenes, and Pseudomonas aeruginosa), and antifungal activities were tested against seven fungal strains (Aspergillus flavus, Aspergillus carbonarious, Aspergillus parasiticus, Aspergillus fumigatus,Aspergillus niger, Fusarium verticillioides and Fusarium proliferatum). The antimicrobial activities of the synthesized compounds were compared with standard streptomycin and nalidixicacid. The results obtained from antibacterial assay indicated that M 1 -M 12 inhibited potential growth of Proteus vulgaris with minimum inhibitory concentrations (MICs) ranging from 15.6-250 μg/mL compared with the standard nalidixic acid with an MIC of 500 μg/mL. Moreover, we could conclude that most of the tested compounds experienced mild to low activities at 15.6 μg/mL. Their activities could be attributed to their low concentrations.The antifungal analysis showed that the tested fungi were not sensitive to the prepared Schiff bases at the prepared concentration of 500 μg/mL. Therefore, we recommended further analysis on both cytotoxicity and minimum bactericidal concentration (MBC) to ascertain their potential effects against human cells.
KW - 4-Aminoantipyrine
KW - Antibacterial
KW - Antifungal
KW - Inhibition
KW - Schiff bases
KW - Synthesis
UR - http://www.scopus.com/inward/record.url?scp=85058149371&partnerID=8YFLogxK
U2 - 10.5246/jcps.2018.11.076
DO - 10.5246/jcps.2018.11.076
M3 - Article
AN - SCOPUS:85058149371
SN - 1003-1057
VL - 27
SP - 753
EP - 766
JO - Journal of Chinese Pharmaceutical Sciences
JF - Journal of Chinese Pharmaceutical Sciences
IS - 11
ER -